Mirtazapine Tablet, Film Coated
Product Images NDC 63629-9255

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 63629-9255). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl636299255)

Label (Lbl636299255)
Mirtazapine 7.5 mg tablet label from Bryant Ranch Prepack, comparing to Remeron 7.5 mg tablet by Aurobindo Pharma USA. The label notes storage at room temperature (20°-25°C), includes a lot number and barcode, and specifies the product is for prescription use only. The NDC 6362992551 is displayed.*
FDA Label Image

Mirtazpine Structure (Mirtazapine Str)

Mirtazpine Structure (Mirtazapine Str)
Chemical structure of mirtazapine, depicting the arrangement of its heterocyclic rings and a methyl group attached to a nitrogen atom. The structure shows multiple fused rings characteristic of this compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.